EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSPNAG00000017013
Gene Symbol: KIF5B
3 Cross references
271 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPNAG00000020638
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPNAG00000011652
Gene Symbol: LOC108414928
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPNAG00000010604
Gene Symbol: LOC108429276
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPNAG00000010611
Gene Symbol: LOC108429275
3 Cross references
157 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSPNAG00000009201
Gene Symbol: LOC108430642
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSPNAG00000023561
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSPNAG00000023929
Gene Symbol: LOC108440557
3 Cross references
210 Possible Orthologues:

Lysyl Oxidase Homolog 2b

Ensembl ID : ENSPNAG00000009552
Gene Symbol: LOC108434263
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor-Like

Ensembl ID : ENSPNAG00000020846
Gene Symbol: LOC108440618
2 Cross references
201 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPNAG00000006708
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPNAG00000025472
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).